The Finnish Medicines Agency (Fimea) compiles, produces, evaluates and distributes evidence-based impartial information on pharmaceuticals to the general. biological preparatory medicine that improves immunity to a particular disease. Research Groups. Fundamental and translational research in the Department of Ophthalmology is conducted by two research groups located in Canthia.
|Published (Last):||13 March 2008|
|PDF File Size:||2.24 Mb|
|ePub File Size:||16.42 Mb|
|Price:||Free* [*Free Regsitration Required]|
Cardiomyoplasty for treatment of heart failure. The influence of corticoids, in chronic Chagas disease, administered in virtue of associated disorders.
Racial differences in response to therapy for heart failure: Autopsy findings in early and late postoperative death after partial left ventriculectomy. Sociedade Brasileira de Hematologia e Hemoterapia.
Strutural and functional analysis of the B cell epitopes recognozed by anti-receptor autoantibodies in patients with Chagas’ Disease. Bone marrow cell transplantation to the myocardium of a patient with heart failure due to Chagas’ disease.
The undetermined form of Chagas’ heart disease: Correlation between T cruzi parasitism and myocardial inflammation in human chronic chagasic myocarditis: Conclusiones y recomendaciones generales. Evaluation and treatment of Chagas’ desease in United States: Conduction defects and arrythmias in Chagas’ Disease: Radionuclide angiographic evidence for early predominant right ventricular involvement in patients with Chagas’ disease.
IC, arritmias e tromboembolismo. Pathogenesis of chronic Chagas heart disease.
Microvascular changes as a cause of chronic cardiomyopathy in Chagas’ disease. Epicardial ablation of ventricular tachycardia in Chagas heart disease. Tarleton RL, Zhang L. Os soropositivos devem ser confirmados por coleta venosa, conforme o esquema abaixo; c.
Acute effects of a single dose of phosphodiesterase type 5 inhibitor sildenafil on systemic arterial blood pressure during exercise and hour ambulatory chagasjca pressure monitoring in heart transplant recipients. Effects of dynamic cardiomyoplasty on regional wall motion, ejection fraction, and geometry of left ventricle. Impact of socioeconomic status on outcome of a Brazilian heart transplant recipients cohort.
A biological approach to sudden cardiac death: J Heart Lung Transplant. Sociedad Argentina de Cardiologia.
Role of autoantibodies in the physiopathology of chagas’ disease
La Iniciativa del Cono Sur. Kluwer Academic Publishers; Relationship of electrocardiographic abnormalities and seropositivity to Trypanosoma cruzi within a rural community in northeast Brazil.
Reversibility of cardiac fibrosis in mice chronically infected with Trypanosoma cruzi, under specific chemotherapy. Peak oxygen consumption and resting left ventricular ejection fraction changes after cardiomyoplasty at 6-month follow-up. Rassi A, Rassi Jr. Early detection of myocardial dysfunction in Chagas disease using novel echocardiographic indices.
Cost-effectiveness of Chagas disease interventions in Latin America and the Caribbean: Surgery and catheter ablation for the treatment of ventricular tachycardia in Chagas’ disease. Hemodynamic and neurohormonal profile during assisted circulation with heterotopic artificial ventricle followed cardiopatix heart transplantation.
Implantable cardioverter defibrillators and Chagas’ disease: Adrenergic nervous system influences on the induction of ventricular tachycardia.
New Employee at the UEF
Ventricular arrhythmia in Chagas disease: Heart transplantation for chronic Chagas’ disease. Chagaasica com IC e ou arritmias graves devem ser desaconselhadas a engravidar. Cardiac thrombosis and embolism in patients having died of chronic Chagas’ cardiopathy. Relevance of apoptosis and cell proliferation for survival of patients with dilated cardiomyopathy undergoing partial left ventriculectomy.
I Latin American Guideline for the Diagnosis and Treatment of Chagas’ Heart Disease
Cardioatia term evaluation of etiological treatment of Chagas disease with benznidazole. The challenge of chagas’ic cardiomyopathy. Later evolution after cardiac transplantation in Chagas’ disease. Predictors of all-cause mortality in chronic Chagas’ heart disease in the current era of heart failure therapy. Transplantation and tropical infectious diseases.
Int J Artif Organs. Emerging acute Chagas disease in Amazonian Brazil: Southern cone initiative carfiopatia the elimination of domestic populations of Triatoma infestans and the interruption of transfusional Chagas disease: Bern C, Montgomery SP.
Wilson Alves de Oliveira Junior Participantes: Early diagnosis of recurrence of Trypanosoma cruzi infection by polymerase chain reaction after heart transplantation of a chronic Chagas’ heart disease patient.
Braz J Med Biol Res. Rev Soc Bras Med Trop. Freilij H, Storino R.